Run it in your lab.
Against your current media.
On your specimens.
A free, structured 2–4 week parallel comparison with full rep support and CAP/CLIA-ready documentation as a direct output. No obligation until you see the data.
Three steps. Your data makes the decision.
The evaluation is not a product trial. It is the regulatory verification your lab already has to complete before switching media — structured, supported, and documented.
Your assigned Oxyrase rep confirms qualification, ships the evaluation kit within 3 business days, and schedules an orientation call with your bench technologist.
Day 0–3Inoculate OxyPlates in parallel with your current media on each qualifying anaerobic specimen. Same technician. Same incubation. One additional plate per specimen.
Weeks 1–4Your rep compiles a structured results summary and presents it to your lab director or decision maker. Your data drives the conversation. A proposal follows within 48 hours — no obligation before you review.
End of Week 4Everything your lab needs. Nothing it doesn’t.
The kit arrives complete, organized, and ready to use. Kit packaging and document design reflect the same clinical professionalism as the product itself.
Sufficient quantity for 30–50 parallel plating events. One OxyPlate per specimen alongside your current media plate. Ambient-air stable — no anaerobic chamber required for inoculation.
Step-by-step protocol written for the bench technologist. Aligned with CAP and CLIA/IQCP requirements. Clinical, procedural, professional — not a marketing brochure.
Pre-formatted 50-specimen parallel comparison spreadsheet with auto-calculated agreement, OxyPlate-only isolate flagging, and built-in QC verification tab. CAP/CLIA documentation-ready as a direct output.
One-page pre-formatted sign-off document meeting CAP accreditation documentation requirements for new media introduction. Ready to sign and file at the debrief.
Direct phone and email for your assigned Oxyrase rep. Same-day response commitment stated explicitly. Your rep is available throughout the evaluation — not just at orientation and debrief.
Why labs run the evaluation
Labs do not run the evaluation as a favor to Oxyrase. They run it because their accreditation requires it before switching media — and because the data is worth having regardless of the outcome.
Anaerobic recovery failure is clinically silent. Labs running underperforming media don’t get an error — they get false negatives. The organisms were there. The evaluation tells you definitively whether yours are being recovered.
OxyPlates are ambient-air stable. Plate it and put it in the incubator. No anaerobic chamber required for inoculation. The workflow difference is visible from the first specimen.
Labs don’t fail to validate because they don’t want to. They stall because building the documentation is time-consuming. The kit includes every form your CAP inspector expects to see. The completed worksheet is the validation summary.
The results debrief presents your lab’s own data back to you. The rep’s role is not to sell — it’s to help you understand what your specimens found. The data makes the case, or it doesn’t.
The lab is already required to validate new media before switching. CAP Checklist item MIC.22750 requires documentation that culture media meets established quality control criteria prior to use. CLIA’s IQCP framework requires in-house performance evidence.
Oxyrase does not create additional work. It provides the structure, documentation, and support to complete the work the lab must do anyway — while ensuring the output produces comparative recovery data worth having.
Not every lab needs to run an evaluation. Here’s who does.
Qualification criteria ensure the evaluation produces meaningful results and represents a viable opportunity for both parties.
No in-house program means no qualifying specimens to run. Referral-only labs do not qualify.
The protocol requires a minimum of 30 clinical specimens. Lower-volume labs can extend the evaluation period to accumulate sufficient comparisons.
Without director or decision-maker buy-in, validation data will not lead to a conversion. We confirm this before shipping a kit.
The lab must be able to complete CAP/CLIA-compliant documentation internally. All templates are provided in the kit.
Everything you need to know before requesting a kit.
Still have questions? Your assigned rep is available same-day.
Start your evaluation
Complete the form and your assigned Oxyrase rep will contact you within one business day to confirm qualification and arrange shipment.
Kit ships within 3 business days of qualification confirmation
Assigned rep throughout — named contact with same-day response commitment
No obligation until you have reviewed your results at the debrief
Direct ordering available — or through Fisher Scientific and Cardinal Health if required by procurement